Work

Allogeneic and other innovative chimeric antigen receptor platforms

Year: 2024

Type: article

Abstract: By Andrew P Jallouk, Salyka Sengsayadeth & 3 more. Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of hematologic malignancies. All of the CAR T-cell products that are currently FDA-approved are autologous.

Source: Clinical Hematology International

DOI: 10.46989/001c.121404

Authors: Andrew P Jallouk, Salyka Sengsayadeth, Bipin N Savani, Bhagirathbhai Dholaria, Olalekan Oluwole

Institution: Vanderbilt University Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4402918315

FWCI: 1.246

Cites: 115

Cited by: 8

Related to: 10